These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 10428778

  • 1. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor.
    Waterman H, Levkowitz G, Alroy I, Yarden Y.
    J Biol Chem; 1999 Aug 06; 274(32):22151-4. PubMed ID: 10428778
    [Abstract] [Full Text] [Related]

  • 2. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
    Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R.
    J Biol Chem; 1999 Oct 29; 274(44):31707-12. PubMed ID: 10531381
    [Abstract] [Full Text] [Related]

  • 3. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
    Thien CB, Walker F, Langdon WY.
    Mol Cell; 2001 Feb 29; 7(2):355-65. PubMed ID: 11239464
    [Abstract] [Full Text] [Related]

  • 4. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML, Miyake S, Meissner-Lula N, Hsu VW, Band H.
    J Biol Chem; 2000 Jan 07; 275(1):367-77. PubMed ID: 10617627
    [Abstract] [Full Text] [Related]

  • 5. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
    Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y.
    Mol Cell; 1999 Dec 07; 4(6):1029-40. PubMed ID: 10635327
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation.
    Jiang X, Sorkin A.
    Traffic; 2003 Aug 07; 4(8):529-43. PubMed ID: 12839496
    [Abstract] [Full Text] [Related]

  • 8. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
    Duan L, Miura Y, Dimri M, Majumder B, Dodge IL, Reddi AL, Ghosh A, Fernandes N, Zhou P, Mullane-Robinson K, Rao N, Donoghue S, Rogers RA, Bowtell D, Naramura M, Gu H, Band V, Band H.
    J Biol Chem; 2003 Aug 01; 278(31):28950-60. PubMed ID: 12754251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
    de Melker AA, van der Horst G, Borst J.
    J Biol Chem; 2004 Dec 31; 279(53):55465-73. PubMed ID: 15465819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex.
    Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, Yarden Y, Weissman AM, Lipkowitz S.
    J Biol Chem; 2001 Jul 20; 276(29):27677-84. PubMed ID: 11375397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
    Ettenberg SA, Rubinstein YR, Banerjee P, Nau MM, Keane MM, Lipkowitz S.
    Mol Cell Biol Res Commun; 1999 Aug 20; 2(2):111-8. PubMed ID: 10542134
    [Abstract] [Full Text] [Related]

  • 18. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
    Haglund K, Schmidt MHH, Wong ES, Guy GR, Dikic I.
    EMBO Rep; 2005 Jul 20; 6(7):635-41. PubMed ID: 15962011
    [Abstract] [Full Text] [Related]

  • 19. D-Cbl binding to Drk leads to dose-dependent down-regulation of EGFR signaling and increases receptor-ligand endocytosis.
    Wang PY, Pai LM.
    PLoS One; 2011 Feb 14; 6(2):e17097. PubMed ID: 21340027
    [Abstract] [Full Text] [Related]

  • 20. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK, Anderson SM.
    J Biol Chem; 2004 Jul 02; 279(27):28017-27. PubMed ID: 15117950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.